Skip to main content
Clinical Trials/NCT04357912
NCT04357912CompletedNot Applicable

Utilizing Activity Trackers to Promote Physical Activity in People With Epilepsy: Can we Make a Difference?

The University of Texas Health Science Center, Houston1 site in 1 country80 target enrollmentStarted: June 16, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
Number of steps taken by participant

Study Overview

Brief Summary

The purpose of this study is to evaluate standard of care exercise education alone or in combination with a wearable physical activity tracker in people with epilepsy (PWE) to determine the most effective way to increase physical activity and measure impact on depression, anxiety, quality of life, sleep, and seizure frequency.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patient of the Texas Comprehensive Epilepsy Program at UTHealth-McGovern Medical School
  • •diagnosis of epilepsy
  • •be able to provide consent in English
  • •complete surveys independently
  • •be able to sync Fitbit data

Exclusion Criteria

  • •currently using a wearable physical activity tracker prior to enrollment
  • •pregnant or planning to become pregnant during the study duration
  • •planning to undergo epilepsy surgery during the study duration

Arms & Interventions

Control Group

Active Comparator

Intervention: Standard of Care Group (Behavioral)

Experimental group

Experimental

Intervention: Activity Tracker Group (Behavioral)

Outcomes

Primary Outcomes

Number of steps taken by participant

Time Frame: 3 months after enrollment

Total time participant is active

Time Frame: 3 months after enrollment

measured in minutes

Total distance traveled by participant

Time Frame: 3 months after enrollment

Secondary Outcomes

  • Quality of life as assessed by the Quality of Life in Epilepsy (QOLIE-10-P) survey(end of study (3 months after enrollment))
  • Anxiety as measured by the General Anxiety Disorder 7-item scale (GAD-7)(end of study (3 months after enrollment))
  • Depression as measured by the Patient Health Questionnaire depression scale (PHQ-9)(end of study (3 months after enrollment))
  • Sleep as measures by the Epworth Sleepiness Scale (ESS)(end of study (3 months after enrollment))
  • Depression as measured by the Patient Health Questionnaire depression scale (PHQ-9)(Baseline)
  • Anxiety as measured by the General Anxiety Disorder 7-item scale (GAD-7)(Baseline)
  • Sleep as measures by the Epworth Sleepiness Scale (ESS)(Baseline)
  • Quality of life as assessed by the Quality of Life in Epilepsy (QOLIE-10-P) survey(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Katherine Marie Johns Harris

Clinical Fellow

The University of Texas Health Science Center, Houston

Study Sites (1)

Loading locations...

Similar Trials